Table 6.

5-year Overall Survival rates for patients with CCC, limited to series with ≥15 patients^**

References	Overall survival (percentage)
	n	All stages	Stage I	Stage II	Stage III	Stage IV
Kurman et al (1976) [14]	21	55.3	NA	NA	NA	NA
Christopherson et al (1982) [8] ¶	54	35.2	44	NA	NA	NA
Webb and Lagios (1987) [30]	29	64	NA	NA	NA	NA
Kanbour-Shakir et al (1991) [29]*	20	60	NA	NA	NA	NA
Carcangiu and Chambers ¶(1995) [31]	29	NA	72	59.2	NA	NA
Malpica et al (1995) [36]¶	17	NA	75	67	NA	NA
Abeler et al (1996) [10,35]	181	46	NA	NA	NA	NA
Thomas et al (2007) [34]	99	55	79	77	47	21
FIGO Data (Creasman et al, 2003) [32] ◙	173	62.5	85.1	66.7	48.5	NA
FIGO Data (Creasman et al, 2004) [33] ◙	59	NA	81	NA	NA	NA
SEER Data (Hamilton et al, 2006) [3]	391	68	NA	NA	NA	NA
Average	97.5 (total 1073)	55.75	72.7	53.32	47.8	21
Current study	50	78	94	87.5	66.7	42.8

^**Excludes any series with mixed carcinomas and without delineation of survival data for the histologically pure cases; excludes series of mixed clear cell/serous carcinomas; includes both surgically and clinically staged patients; includes patients that received a wide variety of treatments; SEER: Surveillance, Epidemiology and End Results; FIGO International Federation of Gynecology and Obstetrics;

^*crude overall survival;

^◙Overlapping datasets; NA information not available or not applicable;

^¶includes series of CCC with a minor (<50%) endometrioid carcinoma component.